We are live on ! Find out more
KXA

KPCB XV Associates Portfolio holdings

AUM $35.8M
1-Year Est. Return 57.59%
This Fund
S&P 500
This Quarter Est. Return
-39.24%
1 Year Est. Return
-57.59%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$77.3M
AUM Growth
-$49.5M
Cap. Flow
+$346K
Cap. Flow %
0.45%
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
TWLO icon
Twilio
TWLO
+$344K
2
AUGX
Augmedix, Inc. Common Stock
AUGX
+$1.92K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 59.47%
2 Technology 40.53%
3 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TWLO icon
1
Twilio
TWLO
$29.8B
$31.3M 40.53%
190,047
+1,887
+1% +$344K
RAPT
2
DELISTED
RAPT Therapeutics
RAPT
$28.5M 36.91%
162,133
– –
ATRA icon
3
Atara Biotherapeutics
ATRA
$77.8M
$17.4M 22.56%
75,066
– –
AUGX
4
DELISTED
Augmedix, Inc. Common Stock
AUGX
$2K ﹤0.01%
+708
New +$1.92K

Similar funds

ALFIA
Accel Leaders Fund II Associates Palo Alto, California $36.6M AUM 58.14% 1-Year Est. Return
KCGDR
Kiron Capital Gestao de Recursos Sao Paulo, Brazil $36.9M AUM 49.85% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
PIM
Ponoi II Management San Francisco, California $38.3M AUM 32.02% 1-Year Est. Return
FCOMV
Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return
SEM
Spectrum Equity Management San Francisco, California $39.1M AUM 63.69% 1-Year Est. Return
MCMI
Matrix China Management III Grand Cayman, Cayman Islands $39.3M AUM
LCM
LH Capital Markets New York $39.4M AUM 14.61% 1-Year Est. Return

KPCB XV Associates's Q1 2022 Portfolio in Review

As of Q1 2022, KPCB XV Associates held 4 positions worth $77.3M, down 39% from $127M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

KPCB XV Associates's Q1 2022 filing shows 1 new and 1 increased positions. Its largest new stake was Augmedix, Inc. Common Stock: 708 shares worth $2K.

By sector, the portfolio is most concentrated in Healthcare at 59% of assets, down from 61% a quarter earlier, followed by Technology and Industrials.

  • KPCB XV Associates's largest Q1 2022 buy was Augmedix, Inc. Common Stock: 708 shares worth $2K.
  • KPCB XV Associates added most to Twilio in Q1 2022, an estimated $344K increase.
  • KPCB XV Associates's ten largest holdings make up 100% of its $77.3M portfolio in Q1 2022.
  • KPCB XV Associates opened 1 new position and closed 0 in Q1 2022.
  • KPCB XV Associates's portfolio value fell 39% quarter-over-quarter to $77.3M.

Based on KPCB XV Associates's 13F filing for Q1 2022, filed 13 May 2022.